Zydus Lifesciences Limited — Updates, 20-05-2025: Press Release

Zydus Lifesciences has announced a board meeting to approve the financial results for the quarter and half-year. Q4 revenue rose 18% to Rs. 6,528 Cr, EBITDA surged 30% with margins expanding to 32.6%, and net profit increased 18% to Rs. 1,391 Cr. For FY25, revenue grew 19% to Rs. 23,242 Cr, EBITDA jumped 31% with 30.4% margins, and net profit increased 23% to Rs. 4,745 Cr. Growth was led by 24% higher US formulations, 13% growth in India formulations, and a 17% rise in consumer wellness, supported by strong R&D and new launches.